Resmed Inc (NYSE: RMD) established initial surge of 0.42% at $256.96, as the Stock market unbolted on Thursday, before settling in for the price of $255.88 at the close. Taking a more long-term approach, RMD posted a 52-week range of $188.06-$263.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 19.83%. Meanwhile, its Annual Earning per share during the time was 19.83%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 22.96%. This publicly-traded company’s shares outstanding now amounts to $146.87 million, simultaneously with a float of $145.60 million. The organization now has a market capitalization sitting at $37.68 billion. At the time of writing, stock’s 50-day Moving Average stood at $247.17, while the 200-day Moving Average is $238.32.
Resmed Inc (RMD) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Resmed Inc industry. Resmed Inc’s current insider ownership accounts for 0.70%, in contrast to 65.98% institutional ownership. According to the most recent insider trade that took place on Jul 02 ’25, this organization’s Director sold 945 shares at the rate of 255.49, making the entire transaction reach 241,438 in total value, affecting insider ownership by 68,273. Preceding that transaction, on Jul 01 ’25, Company’s Chief Financial Officer sold 3,883 for 256.99, making the whole transaction’s value amount to 997,892. This particular insider is now the holder of 84,283 in total.
Resmed Inc (RMD) Earnings and Revenue Records
Resmed Inc’s EPS increase for this current 12-month fiscal period is 22.96% and is forecasted to reach 10.59 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 14.63% through the next 5 years, which can be compared against the 19.83% growth it accomplished over the previous five years trading on the market.
Resmed Inc (NYSE: RMD) Trading Performance Indicators
Let’s observe the current performance indicators for Resmed Inc (RMD). It’s Quick Ratio in the last reported quarter now stands at 2.49. Alongside those numbers, its PE Ratio stands at $28.85, and its Beta score is 0.77. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.50. Similarly, its price to free cash flow for trailing twelve months is now 24.02.
In the same vein, RMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 8.91, a figure that is expected to reach 2.48 in the next quarter, and analysts are predicting that it will be 10.59 at the market close of one year from today.
Technical Analysis of Resmed Inc (RMD)
Now, what If we examine the latest scores posted by [Resmed Inc, RMD]. During the last 5-days, its volume was lower the volume of 0.99 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 60.50% While, its Average True Range was 3.88.
Raw Stochastic average of Resmed Inc (RMD) in the period of the previous 100 days is set at 94.58%, which indicates a major rise in contrast to 72.81% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 11.33% that was lower than 29.07% volatility it exhibited in the past 100-days period.
